Retention behavior of neutral and positively and negatively charged solutes on an immobilized-artificial-membrane (IAM) stationary phase

Helvetica Chimica Acta

Volumn 91, Issue 8, 2008, Pages 1505-1512

  Liu, Xiangli ^a   Hefesha, Hossam ^a   Scrib, Gerhard ^a   Fahr, Alfred ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACRIDINE; ALIPHATIC AMINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBOXYLIC ACID DERIVATIVE; CORTICOSTERONE; DEXAMETHASONE; DIHYDROPYRIDINE; ESTRADIOL; ESTRONE; FLURBIPROFEN; HYDROCORTISONE; HYDROCORTISONE ACETATE; INDOMETACIN; KETOPROFEN; MEFENAMIC ACID; METIPRANOLOL; METOPROLOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXPRENOLOL; PENBUTOLOL; PHOSPHOLIPID; PINDOLOL; PROGESTERONE; PROPRANOLOL DERIVATIVE; TESTOSTERONE;

ARTICLE; ARTIFICIAL MEMBRANE; DRUG RETENTION; DRUG STABILITY; DRUG STRUCTURE; ELECTRICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPOPHILICITY; PH; PRIORITY JOURNAL;

EID: 55449104330     PISSN: 0018019X     EISSN: None     Source Type: Journal    
DOI: 10.1002/hlca.200890164     Document Type: Article

References (29)

1. H. van de Waterbeemed, B. Testa, in 'Advances in Drug Research', Ed. B. Testa, Academic Press, London, 1987, Vol. 16, p. 87-227.
2. G. Camenisch, G. Folkers, H. van de Waterbeemed, Pharm. Acta Helv. 1996, 71, 309.
3. I. Komiya, J. Y. Park, A. Kamani, N. F. H. Ho, W. I. Higuchi, Int. J. Pharm. 1980, 4, 249.
4. D. C. Taylor, R. Pownall, W. Burke, J. Pharm. Pharmacol. 1985, 37, 280.
5. V. A. Levin, J. Med. Chem. 1980, 23, 682.
6. P. Artursson, J. Pharm. Sci. 1990, 79, 476.
7. A. Buur, L. Trier, C. Magnusson, P. Artursson, Int. J. Pharm. 1996, 129, 223.
8. A. R. Hilgers, R. A. Conradi, P. S. Burton, Pharm. Res. 1990, 7, 902.
9. L. Hovgaard, H. Brondsted, A. Buur, H. Bundgaard, Pharm. Res. 1995, 12, 387.
10. M. S. Roberts, W. J. Pugh, J. Hadgraft, A. C. Watkinson, Int. J. Pharm. 1995, 126, 219.
11. M. S. Roberts, W. J. Pugh, J. Hadgraft, Int. J. Pharm. 1996, 132, 23.
12. W. J. Pugh, M. S. Roberts, J. Hadgraft, Int. J. Pharm. 1996, 138, 149.
13. O. A. Raevsky, V. I. Fetisov, E. P. Trepalina, J. W. McFarland, K. J. Schaper, Quant. Struct.-Act. Relat. 2000, 19, 366.
14. F. Wohnsland, B. Faller, J. Med. Chem. 2001, 44, 923
15. B. Testa, P. A. Carrupt, P. Gaillard, R. S. Tsai, in 'Lipophilicity in Drug Action and Toxicology', Eds. V. Pliska, B. Testa, and H. van de Waterbeemed, VCH, Weinheim, Germany, 1996, pp. 275-304.
16. J. Comer, K. Tam, in 'Pharmacokinetics Optimization in Drug Research: Biological, Physicochemical and Computational Strategies', Eds. B. Testa, H. van de Waterbeemed, G. Folkers, and R. H. Guy, Wiley-VHCA, ZJrich, 2001, pp. 275-304.
17. S. Ong, S. J. Cai, C. Barnal, D. Rhee, X. Qiu, C. Pidgeon, Anal. Chem. 1994, 66, 782.
18. S. Ong, H. Liu, C. Pidgeon, J. Chromatogr. A 1996, 728, 113.
19. F. Barbato, G. di Martino, L. Grumetto, M. I. La Rotonda, Eur. J. Pharm. Sci. 2005, 25, 379.
20. R. Kaliszan, A. Nasal, A. Bucinski, Eur. J. Med. Chem. 1994, 29, 163.
21. F. Barbato, M. I. La Rotonda, F. Quaglia, J. Pharm. Sci. 1997, 86, 225.
22. F. Barbato, M. I. La Rotonda, F. Quaglia, Eur. J. Med. Chem. 1996, 31, 311.
23. Bioloom version 1, Biobyte Corporation, Clarement, CA.
24. A. Taillardat-Bertschinger, C. A. Marca Martinet, P. A. Carrupt, M. Reist, G. Caron, R. Fruttero, B. Testa, Pharm. Res. 2002, 19, 729.
25. C. A. Marca Martinet, Ph.D Thesis, University of Lausanne, 2001.
26. H. Tomida, T. Yotsuyanagi, K. Ikeda, Chem. Pharm. Bull. 1978, 26, 2832.
27. A. Avdeef, K. J. Box, J. E. A. Comer, C. Hibbert, K. Y. Tam, Pharm. Res. 1998, 15, 209.
28. F. Barbato, G. di Martino, L. Grumetto, M. I. La Rotonda, Eur. J. Pharm. Sci. 2004, 22, 261.
29. W. R. Meindl, E. von Angerer, H. Schönenberger, G. Ruckdeschel, J. Med. Chem. 1984, 27, 1111.